✦ LIBER ✦

776 PATIENT EDUCATION IMPROVES ADHERENCE TO PEGINTERFERON AND RIBAVIRIN IN CHRONIC GENOTYPE 2 OR 3 HEPATITIS C VIRUS (HCV) INFECTION IN THE REAL-LIFE

✍ Scribed by P. Cacoub; P. Melin; D. Ouzan; L. Cattan; M. Chousterman; M. Varastet; M. Rotily; T. Fontanges; J.P. Lang; P. Marcellin

Book ID: 117376702
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 70 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60778-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2b plus ribavirin for

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3

✍ Stefan Zeuzem; Rolf Hultcrantz; Marc Bourliere; Tobias Goeser; Patrick Marcellin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Randomized comparison of 12 or 24 weeks

Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

✍ Martin Lagging; Nina Langeland; Court Pedersen; Martti Färkkilä; Mads Rauning Bu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

Previous trials investigating the efficacy of treatment durations shorter than the standard of 24 weeks for chronic hepatitis C virus (HCV) genotype 2/3 infections have yielded discordant results. The aims of this investigator-initiated phase III study were to compare the efficacy of 12 or 24 weeks

940 Predicitive Factors for Nonresponse

940 Predicitive Factors for Nonresponse in Genotype 2/3 Infected Chronic Hepatitis C (CHC) Patients Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV) in Real Life Setting

✍ Petersen, Jörg; Lutz, Thomas; Link, Ralph; Moog, Gero; Baumgarten, Axel; Schott, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 148 KB

1149 PREDICTIVE FACTORS FOR NONRESPONSE

1149 PREDICTIVE FACTORS FOR NONRESPONSE IN GENOTYPE 2/3 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING

✍ Petersen, J.; Lutz, T.; Link, R.; Moog, G.; Baumgarten, A.; Schott, E.; Schmidt, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Retreatment with peg-interferon and riba

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

✍ Lagging, Martin; Rembeck, Karolina; Rauning Buhl, Mads; Christensen, Peer; Dalga 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 425 KB

Corrigendum to “Peginterferon alfa-2b pl

Corrigendum to “Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3” [J Hepatol 40 (2004) 939–999]

✍ Stefan Zeuzem; Rolf Hultcrantz; Marc Bourliere; Tobias Goeser; Patrick Marcellin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB